A brief review of the current breast cancer prevention trials and proposals for future trials (Q33959743)

30 July 2017

A brief review of the current breast cancer prevention trials and proposals for future trials (English)

1 reference

30 July 2017

Cuzick J

1

1 reference

30 July 2017

1 June 2000

1 reference

European Journal of Cancer

30 July 2017

1 reference

30 July 2017

36

1 reference

30 July 2017

10

1 reference

30 July 2017

1298-1302

1 reference

Tamoxifen and contralateral breast cancer

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

The prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Prevention of breast cancer with tamoxifen--an update on the Royal Marsden Hospital pilot programme

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900106-4

7 January 2021

10.1016/S0959-8049(00)00106-4

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

10882870